Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4U91

GephE in complex with Para-Phenyl crosslinked Glycine receptor beta subunit derived dimeric peptide

Summary for 4U91
Entry DOI10.2210/pdb4u91/pdb
Related4PD0 4PD1 4TK1 4TK2 4TK3 4TK4 4U90
DescriptorGephyrin, Glycine receptor subunit beta, ACETATE ION, ... (7 entities in total)
Functional Keywordstransferase, scaffolding protein, inhibitory synapse, gaba type a receptor, transfer protein - structural protein complex, transfer protein / structural protein
Biological sourceRattus norvegicus (Rat)
More
Cellular locationCell junction, synapse : Q03555
Total number of polymer chains3
Total formula weight48470.57
Authors
Kasaragod, V.B.,Maric, H.M.,Schindelin, H. (deposition date: 2014-08-05, release date: 2014-12-10, Last modification date: 2023-12-20)
Primary citationMaric, H.M.,Kasaragod, V.B.,Haugaard-Kedstrom, L.,Hausrat, T.J.,Kneussel, M.,Schindelin, H.,Strmgaard, K.
Design and Synthesis of High-Affinity Dimeric Inhibitors Targeting the Interactions between Gephyrin and Inhibitory Neurotransmitter Receptors.
Angew.Chem.Int.Ed.Engl., 54:490-494, 2015
Cited by
PubMed Abstract: Gephyrin is the central scaffolding protein for inhibitory neurotransmitter receptors in the brain. Here we describe the development of dimeric peptides that inhibit the interaction between gephyrin and these receptors, a process which is fundamental to numerous synaptic functions and diseases of the brain. We first identified receptor-derived minimal gephyrin-binding peptides that displayed exclusive binding towards native gephyrin from brain lysates. We then designed and synthesized a series of dimeric ligands, which led to a remarkable 1220-fold enhancement of the gephyrin affinity (KD=6.8 nM). In X-ray crystal structures we visualized the simultaneous dimer-to-dimer binding in atomic detail, revealing compound-specific binding modes. Thus, we defined the molecular basis of the affinity-enhancing effect of multivalent gephyrin inhibitors and provide conceptually novel compounds with therapeutic potential, which will allow further elucidation of the gephyrin-receptor interplay.
PubMed: 25413248
DOI: 10.1002/anie.201409043
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

238268

數據於2025-07-02公開中

PDB statisticsPDBj update infoContact PDBjnumon